Aarti Drugs Ltd Share Price (AARTIDRUGS)
Check the latest share price of Aarti Drugs Ltd, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.
as on 04:01PM, 13 Jun 2025
NSE
Aarti Drugs Ltd Stock Performance
Get live Aarti Drugs Ltd share price, day's high and low, historical returns, and market stats.
Day's Low
Day's High
₹459.05Day's Price Range₹47252 Week's Low
52 Week's High
₹31252-Week Price Range₹635
| Returns % | |
| 1 Month Return | + 0.28 % |
| 3 Month Return | + 39.18 % |
| 1 Year Return | -11.02 % |
| 3 Year Return | + 11.36 % |
| 5 Year Return | + 90.34 % |
| Market Stats | |
| Previous Close | ₹473.60 |
| Open | ₹471.00 |
| Volume | 2.03L |
| Upper Circuit | ₹568.30 |
| Lower Circuit | ₹378.90 |
Aarti Drugs Ltd Fundamentals & Key Indicators
Check Aarti Drugs Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹4,263.49 Cr
Return on Equity (ROE)
12.39
PE Ratio (TTM)
25.75
Return on capital employed (ROCE)
13.65
Industry PE ratio
57.51
Beta (LTM)
0.7
P/B Ratio
3.39
Dividend Yield
0.23
PEG Ratio
-117.06
Quarterly Earnings Growth YOY
32.68
EPS (TTM)
18.66
Sector
Pharmaceuticals
Book Value
139.4
Technical Analysis
Bullish
View Technical Analysis
How to invest in Aarti Drugs Ltd?
Investing in Aarti Drugs Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Aarti Drugs Ltd or AARTIDRUGS on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of Aarti Drugs Ltd or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Aarti Drugs Ltd with just a few clicks!
Aarti Drugs Ltd Stock's Interest Amongst Investors
Aarti Drugs Ltd Valuation
Track how Aarti Drugs Ltd P/E has moved over time to understand its valuation trends.
Aarti Drugs Ltd in the last 5 years
Lowest (8.29x)
March 31, 2020
Today (25.75x)
June 12, 2025
Industry (57.51x)
June 12, 2025
Highest (57.24x)
August 24, 2020
Today’s Price to Earnings Ratio: 25.75x
Aarti Drugs Ltd Stock Recommendation
Get updated buy, sell, and hold recommendations by analysts on Aarti Drugs Ltd.
based on 1 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
100% of analysts recommend a 'BUY' rating for Aarti Drugs Ltd. Average target price of ₹461
Source: S&P Global Market Intelligence
Aarti Drugs Ltd Share Price Target
Get share price movements and forecasts by analysts on Aarti Drugs Ltd.
Aarti Drugs Ltd price forecast by 1 analysts
Downside of-0.59%
High
₹461
Target
₹461.00
Low
₹461
Aarti Drugs Ltd target price ₹461, a slight downside of -0.59% compared to current price of ₹463.75. According to 1 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Aarti Drugs Ltd revenue growth forecast
Expected growth rate Q1, FY2027:19.72%
Forecast
Actual
Including amortisation and stock based compensations
Aarti Drugs Ltd EPS growth forecast
EPS estimate Q1, FY2027:51.74%
Forecast
Actual
Source: S&P Global Market Intelligence
Aarti Drugs Ltd Financial Results
Get the annual and quarterly financial summary of Aarti Drugs Ltd, including revenue, profit, loss and more.
Indices Featuring Aarti Drugs Ltd Stock
Check stock indices that include Aarti Drugs Ltd.
Aarti Drugs Ltd Earnings and Dividends
View detailed summary of the earnings and dividend history of Aarti Drugs Ltd.
Aarti Drugs Ltd Earnings Results
Aarti Drugs Ltd’s net profit jumped 32.7% since last year same period to ₹62.86Cr in the Q4 2024-2025. On a quarterly growth basis, Aarti Drugs Ltd has generated 69.66% jump in its net profits since last 3-months.
Read More about Earnings ResultsAarti Drugs Ltd Dividends January,2025
In the quarter ending December 2024, Aarti Drugs Ltd has declared dividend of ₹1 - translating a dividend yield of 0.22%.
Read More about Dividends
Aarti Drugs Ltd Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Aarti Drugs Ltd.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 55.48% | 0.00 | |
| Foreign Institutions | 2.25% | 0.00 | |
| Mutual Funds | 8.75% | 0.00 | |
| Retail Investors | 32.57% | 0.00 | |
| Others | 0.95% | 0.00 |
Aarti Drugs Ltd vs Peers
Compare market cap, revenue, PE, and other key metrics of Aarti Drugs Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 4,263.49 | 18.07% | 0.64 | 171 | 2,528 | |
| BUY | 38,428.87 | 101.79% | 0.52 | 300 | 1,051 | |
| BUY | 17,430.61 | 17.42% | 0.57 | 72 | 6,702 | |
| NA | 5,383.81 | 2.8% | 0.79 | -388 | 75 | |
| BUY | 14,436.59 | 43.15% | 0.68 | 244 | 1,515 |
Aarti Drugs Ltd News & Key Events
Latest news and events in one place to help you make informed investing decisions in Aarti Drugs Ltd.
Aarti Drugs Reports Strong Q4 Results, Shares Surge - 07 May, 2025
Aarti Drugs shares rose significantly after the company reported robust Q4 FY25 results, including a 33% YoY net profit increase and 21.54% revenue growth QoQ. The stock surged 14% and later skyrocketed 18% following the announcement, reflecting strong market confidence.Aarti Drugs Reports Strong Quarterly Profit Growth - 06 May, 2025
Aarti Drugs' consolidated net profit surged 32.7% to ₹62.86 crore in the March 2025 quarter, despite a 1.9% decline in annual profit. Sales also increased by 9.16% in the quarter.Aarti Drugs Schedules Q4 FY25 Earnings Call - 30 Apr, 2025
Aarti Drugs Limited has announced an earnings conference call on May 7, 2025, to discuss its financial performance for Q4 FY25, providing insights for investors and analysts.
Insights on Aarti Drugs Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 4 quarters, 33.24 Cr → 62.86 Cr (in ₹), with an average increase of 17.2% per quarter
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 7.78% to 8.75% in Mar 2025 quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 568.5 Cr → 678.63 Cr (in ₹), with an average increase of 16.2% per quarter
- POSITIVE IMPACT
Promoter Holding Up
Promoters have increased holdings from 55.38% to 55.48% in Mar 2025 quarter
- POSITIVE IMPACT
Price Rise
In the last 3 months, AARTIDRUGS stock has moved up by 39.2%
NO EFFECTAgainst Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 131.1% return, outperforming this stock by 119.7%
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 45.3% return, outperforming this stock by 56.3%
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 33.57% to 32.57% in Mar 2025 quarter
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 2.28% to 2.25% in Mar 2025 quarter
About Aarti Drugs Ltd
Revenue: ₹676.76Cr as on March 2025 (Q4 FY25)
Net Profit: ₹62.77Cr as on March 2025 (Q4 FY25)
Listing date: 03 Oct, 1996
Chairperson Name: Prakash M Patil
| Organisation | Aarti Drugs Ltd |
| Headquarters | Mumbai |
| Industry | Pharmaceuticals |
| CEO | Prakash M Patil |
| E-voting on shares | Click here to vote |
Mutual Funds that own Aarti Drugs Ltd
Check out the Mutual Funds with significant holdings in Aarti Drugs Ltd.
FAQs
What is Aarti Drugs Ltd share price today?
Aarti Drugs Ltd share price today stands at ₹463.75, Open: ₹471, Previous Close: ₹473.6, High: ₹472, Low: ₹459.05, 52 Week High: ₹635, 52 Week Low: ₹312.
What is today's traded volume of Aarti Drugs Ltd?
Today's traded volume of Aarti Drugs Ltd is 2.03L. Which means that 2.03L shares of Aarti Drugs Ltd were bought and sold on the stock market during today's trading session.
What is Aarti Drugs Ltd's market cap today?
Today's market capitalisation of Aarti Drugs Ltd is ₹4,263.49 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
What is the 52 week high and 52 week low range of Aarti Drugs Ltd?
Aarti Drugs Ltd’s 52 week high is ₹635 and 52 week low is ₹312. The current share price of Aarti Drugs Ltd is ₹463.75, which is -26.97% down from its 52 week high and 48.64% up from its 52 week low.